Skip to main content

Table 3 Albuminuria and blood pressures at the time of diagnosis and after 6 months of allograft IgAN patients who had complete information

From: Possible beneficial association between renin-angiotensin-aldosterone-system blockade usage and graft prognosis in allograft IgA nephropathy: a retrospective cohort study

 

At allograft IgAN diagnosis

After 6 months

Dipstick albuminuria

None or trace

1+

≥2+

None or trace

1+

≥2+

 No medication (N = 216)

143 (66.2%)

22 (10.2%)

51 (23.6%)

166 (76.9%)

26 (12.0%)

24 (11.1%)

 Single RAASB (N = 38)

9 (23.7%)

8 (21.1%)

21 (55.3%)

18 (47.4%)

7 (18.4%)

13 (34.2%)

 Single BB/CCB (N = 28)

19 (67.9%)

5 (17.9%)

4 (14.3%)

15 (53.6%)

4 (14.3%)

9 (32.1%)

 Combination (N = 94)

34 (36.2%)

10 (10.6%)

50 (53.2%)

33 (35.1%)

18 (19.1%)

43 (45.7%)

Blood pressure

Systolic BP

Diastolic BP

MAP

Systolic BP

Diastolic BP

MAP

 No medication (N = 268)

129.0 [117.0–138.0]

78.0 [70.0–85.5]

95.0 [85.5–102.7]

125.0 [116.0–135.0]

76.0 [68.0–84.0]

92.7 [84.5–100.2]

 Single RAASB (N = 33)

120.0 [110.0–133.0]

74.0 [65.0–80.0]

88.7 [81.7–98.7]

122.0 [118.0–136.0]

81.0 [72.0–88.0]

94.7 [90.0–103.3]

 Single BB/CCB (N = 28)

120.0 [114.5–136.0]

79.0 [69.5–87.0]

93.2 [84.5–100.3]

126.5 [116.5–140.0]

79.0 [70.5–84.0]

94.2 [85.8–103.3]

 Combination (N = 104)

129.0 [118.5–139.5]

80.0 [70.0–88.0]

96.3 [88.0–103.3]

128.0 [116.0–140.0]

79.0 [70.0–87.0]

93.7 [85.0–103.8]

  1. IgAN Immunoglobulin A nephropathy, RAASB Renin-angiotensin-aldosterone blockades, BB Beta blockers, CCB Calcium channel blockers, BP Blood pressure, MAP Mean arterial pressure